501 related articles for article (PubMed ID: 20200418)
1. Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy.
Kachlany SC
J Dent Res; 2010 Jun; 89(6):561-70. PubMed ID: 20200418
[TBL] [Abstract][Full Text] [Related]
2. Relationship of serotype, leukotoxin gene type and lysogeny in Actinobacillus actinomycetemcomitans to periodontal disease status.
Barretto Tinoco EM; Stevens R; Haubek D; Lai CH; Balachandran S; Preus H
Eur J Oral Sci; 1997 Aug; 105(4):310-7. PubMed ID: 9298362
[TBL] [Abstract][Full Text] [Related]
3.
Vega BA; Belinka BA; Kachlany SC
Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31454891
[No Abstract] [Full Text] [Related]
4. Microbiological and immunological characteristics of young Moroccan patients with aggressive periodontitis with and without detectable Aggregatibacter actinomycetemcomitans JP2 infection.
Rylev M; Bek-Thomsen M; Reinholdt J; Ennibi OK; Kilian M
Mol Oral Microbiol; 2011 Feb; 26(1):35-51. PubMed ID: 21214871
[TBL] [Abstract][Full Text] [Related]
5. Relationship between conversion of localized juvenile periodontitis-susceptible children from health to disease and Actinobacillus actinomycetemcomitans leukotoxin promoter structure.
Bueno LC; Mayer MP; DiRienzo JM
J Periodontol; 1998 Sep; 69(9):998-1007. PubMed ID: 9776028
[TBL] [Abstract][Full Text] [Related]
6. Clonal diversity of Actinobacillus actinomycetemcomitans isolates from young adults with minimal periodontal disease.
Macheleidt A; Müller HP; Eger T; Putzker M; Zöller L
J Periodontal Res; 1999 May; 34(4):179-87. PubMed ID: 10444741
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathogenicity of the oral opportunistic pathogen Actinobacillus actinomycetemcomitans.
Henderson B; Nair SP; Ward JM; Wilson M
Annu Rev Microbiol; 2003; 57():29-55. PubMed ID: 14527274
[TBL] [Abstract][Full Text] [Related]
8. Aggregatibacter (Actinobacillus) actimycetemcomitans leukotoxin and human periodontitis - A historic review with emphasis on JP2.
Tsai CC; Ho YP; Chou YS; Ho KY; Wu YM; Lin YC
Kaohsiung J Med Sci; 2018 Apr; 34(4):186-193. PubMed ID: 29655406
[TBL] [Abstract][Full Text] [Related]
9. TdeA, a TolC-like protein required for toxin and drug export in Aggregatibacter (Actinobacillus) actinomycetemcomitans.
Crosby JA; Kachlany SC
Gene; 2007 Feb; 388(1-2):83-92. PubMed ID: 17116373
[TBL] [Abstract][Full Text] [Related]
10. Generation of a recombinant Aggregatibacter actinomycetemcomitans RTX toxin in Escherichia coli.
Balashova N; Giannakakis A; Brown AC; Koufos E; Benz R; Arakawa T; Tang HY; Lally ET
Gene; 2018 Sep; 672():106-114. PubMed ID: 29879499
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the role of highly leukotoxic Actinobacillus actinomycetemcomitans in the pathogenesis of localized juvenile and other forms of early-onset periodontitis.
Haraszthy VI; Hariharan G; Tinoco EM; Cortelli JR; Lally ET; Davis E; Zambon JJ
J Periodontol; 2000 Jun; 71(6):912-22. PubMed ID: 10914794
[TBL] [Abstract][Full Text] [Related]
12. Absence of an especially toxic clone among isolates of Actinobacillus actinomycetemcomitans recovered from army recruits.
Macheleidt A; Müller HP; Eger T; Putzker M; Fuhrmann A; Zöller L
Clin Oral Investig; 1999 Dec; 3(4):161-7. PubMed ID: 10803129
[TBL] [Abstract][Full Text] [Related]
13. Profound Effects of Aggregatibacter actinomycetemcomitans Leukotoxin Mutation on Adherence Properties Are Clarified in in vitro Experiments.
Velusamy SK; Sampathkumar V; Godboley D; Fine DH
PLoS One; 2016; 11(3):e0151361. PubMed ID: 26977924
[TBL] [Abstract][Full Text] [Related]
14. Frequency of 530-bp deletion in Actinobacillus actinomycetemcomitans leukotoxin promoter region.
Contreras A; Rusitanonta T; Chen C; Wagner WG; Michalowicz BS; Slots J
Oral Microbiol Immunol; 2000 Oct; 15(5):338-40. PubMed ID: 11154428
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Aggregatibacter (Actinobacillus) actinomycetemcomitans leukotoxin secretion by iron.
Balashova NV; Diaz R; Balashov SV; Crosby JA; Kachlany SC
J Bacteriol; 2006 Dec; 188(24):8658-61. PubMed ID: 17041062
[TBL] [Abstract][Full Text] [Related]
16. Cellular and molecular response of human macrophages exposed to Aggregatibacter actinomycetemcomitans leukotoxin.
Kelk P; Abd H; Claesson R; Sandström G; Sjöstedt A; Johansson A
Cell Death Dis; 2011 Mar; 2(3):e126. PubMed ID: 21390060
[TBL] [Abstract][Full Text] [Related]
17. Increased leukotoxin production: Characterization of 100 base pairs within the 530 base pair leukotoxin promoter region of Aggregatibacter actinomycetemcomitans.
Sampathkumar V; Velusamy SK; Godboley D; Fine DH
Sci Rep; 2017 May; 7(1):1887. PubMed ID: 28507341
[TBL] [Abstract][Full Text] [Related]
18. Antibody reactive with Actinobacillus actinomycetemcomitans leukotoxin in early-onset periodontitis patients.
Califano JV; Pace BE; Gunsolley JC; Schenkein HA; Lally ET; Tew JG
Oral Microbiol Immunol; 1997 Feb; 12(1):20-6. PubMed ID: 9151640
[TBL] [Abstract][Full Text] [Related]
19. Attachment loss in Moroccan early onset periodontitis patients and infection with the JP2-type of Actinobacillus actinomycetemcomitans.
Haubek D; Ennibi OK; Abdellaoui L; Benzarti N; Poulsen S
J Clin Periodontol; 2002 Jul; 29(7):657-60. PubMed ID: 12354092
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of synthetic histatin 5 on leukotoxin from Actinobacillus actinomycetemcomitans.
Murakami Y; Xu T; Helmerhorst EJ; Ori G; Troxler RF; Lally ET; Oppenheim FG
Oral Microbiol Immunol; 2002 Jun; 17(3):143-9. PubMed ID: 12030965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
